Skip to content

A systematic review of the skin moisturizing effects of Astaxanthin.

A systematic review of the skin moisturizing effects of Astaxanthin. - A systematic review of the skin moisturizing effects of Astaxanthin.

Status
Active, not recruiting
Phases
Unknown
Study type
Unknown
Source
JPRN
Registry ID
JPRN-UMIN000055048
Enrollment
Unknown
Registered
2024-07-23
Start date
2024-07-24
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Persons not suffering from any disease (excluding persons under 18 years of age, pregnant or nursing mothers)

Interventions

None listed

Sponsors

FUJIFILM Corporation
Lead Sponsor
Yakujihou Marketing Jimusho Co., Ltd.
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: A systematic literature search is performed through scientific and clinical trial registries databases. The selection criteria are as follows. P-Persons not suffering from any disease (excluding persons under 18 years of age, pregnant or nursing mothers) I-Intervention: Oral intake of astaxanthin-containing foods (tablets, capsules, granules, beverages, foods). Compositions containing other ingredients (compositions that also contain ingredients other than astaxanthin as the test substance are excluded.) Combination compositions with other ingredients (compositions that contain ingredients other than astaxanthin as the test substance will be excluded). Astaxanthin intake should be between 0.4 and 30 mg/day. C-Control: The comparison control will be the consumption of a placebo food that does not contain the relevant functional substances. O-Outcome: The primary outcome will evaluate the ability to help protect skin moisture. The effect on skin moisture will be evaluated. Specifically, Skin moisture content and Transepidermal water loss are used as endpoints, and both outcomes will be evaluated comprehensively. S-Study design: Randomized, quasi-randomized, and non-randomized controlled trials (parallel group or crossover controlled trials) will be included.

Exclusion criteria

Exclusion criteria: Studies which do not meet the key inclusion criteria will be excluded.

Design outcomes

Primary

MeasureTime frame
The primary outcome will evaluate the ability to help protect skin moisture. The effect on skin moisture will be evaluated. Specifically, Skin moisture content and Transepidermal water loss are used as endpoints, and both outcomes will be evaluated comprehensively.

Countries

Japan

Contacts

Public ContactYuriko Oda

FUJIFILM Corporation Consumer Healthcare Business Div.

Yuriko.oda@fujifilm.com090-2547-9721

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026